ENTA - Enanta Pharmaceuticals' (ENTA) CEO Jay Luly on Q4 2019 Results - Earnings Call Transcript
Enanta Pharmaceuticals, Inc. (ENTA)
Q4 2019 Earnings Conference Call
November 21, 2019, 04:30 PM ET
Company Participants
Carol Miceli - Director, IR
Jay Luly - President and CEO
Paul Mellett - CFO
Nathalie Adda - SVP and Chief Medical Officer
Conference Call Participants
Brian Abrahams - RBC Capital Markets
Jay Olson - Oppenheimer
Paul O'Brien - ROTH Capital
Liisa Bayko - JMP Securities
Patrick Trucchio - Berenberg Capital Markets
Jack Allen - Baird
Akash Tewari - Wolfe Research
Presentation
Operator
Ladies and gentlemen thank you for standing by and welcome to the Enanta Pharmaceuticals Fourth